[1]
“The renin-angiotensin-aldosterone system inhibitors in COVID-19: from acidosis to ventilation and immunity”, Swiss Med Wkly, vol. 150, no. 4950, p. w20444, Dec. 2020, doi: 10.4414/smw.2020.20444.